ROSENTHAL, ARNON,LEVITEN, MICHAEL,VERKMAN, ALAN, S.
申请号：
EP14782979
公开号：
EP2983710A4
申请日:
2014.04.09
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present disclosure relates generally to methods of preventing, reducing risk of developing, or treating neuromyelitis optica (NMO) and, more specifically, to methods involving the inhibition of the classical pathway of complement activation.
